| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |